Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Manjistha (Rubia cordifolia) contains purpurin and alizarin compounds that support detoxification through enhanced lymphatic drainage. These anthraquinone glycosides also inhibit tyrosinase enzyme activity to reduce skin pigmentation and promote even skin tone.
Reported Benefits (Provisional)
Origin & History
Manjistha, or Rubia cordifolia, is a perennial climbing plant found in the Himalayas and other regions of India. It is prized for its vibrant red roots, which are used for their medicinal properties.
Research Narrative (Provisional)
Studies on Manjistha have shown its potential in promoting skin health and supporting the lymphatic system. Research includes both in vitro and in vivo studies.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
{"macronutrients": {"fiber": "Approximately 2-3% of dry weight"}, "micronutrients": {"calcium": "Around 200 mg/100g", "iron": "Approximately 5 mg/100g", "magnesium": "Roughly 80 mg/100g"}, "bioactive_compounds": {"anthraquinones": "Includes compounds like purpurin and munjistin, concentrations vary", "glycosides": "Contains compounds such as ruberythric acid, concentrations vary"}, "bioavailability_notes": "The bioavailability of anthraquinones can be influenced by the method of preparation and consumption. The presence of fiber may aid in the gradual release and absorption of nutrients."}
Reported Mechanism (Provisional)
Manjistha's primary bioactives purpurin and alizarin enhance lymphatic circulation by stimulating lymphatic vessel contractions and improving fluid drainage. The anthraquinone compounds inhibit tyrosinase enzyme activity, reducing melanin production and decreasing hyperpigmentation. Its diuretic effects occur through increased sodium and chloride excretion via the kidneys.
Clinical Narrative (Provisional)
Limited human studies exist for manjistha, with most research conducted in animal models and in vitro studies. A small pilot study (n=30) showed 40% reduction in melasma severity after 12 weeks of topical application. Animal studies demonstrate hepatoprotective effects and enhanced lymphatic function, but larger randomized controlled trials in humans are needed to confirm therapeutic efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.